26 results
SC 13D/A
EX-3
10X Fund, L.P.
1 Dec 23
GALECTIN THERAPEUTICS / 10X Fund ownership change
4:38pm
10-K
2022 FY
EX-3.7
GALT
Galectin Therapeutics Inc.
Annual report
30 Mar 23
7:52am
8-K
EX-3.2
GALT
Galectin Therapeutics Inc.
19 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
GALT
Galectin Therapeutics Inc.
19 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.3
GALT
Galectin Therapeutics Inc.
19 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
j2i9f 1c321vy
17 Feb 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
6umymq w91s7mfwljad
27 Sep 16
Galectin Therapeutics Announces Top-Line Data from Exploratory Phase 2a Pilot Trial (NASH-FX) with GR-MD-02 in NASH Patients with Advanced Fibrosis
12:00am
8-K
EX-3.1
3ijxmtlqdol4se8qx
30 May 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.2
3k86qf6bkz 9eo
30 May 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.1
10hgrp3 px532ux
23 Mar 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
xckv1vwf6zgvx sey76k
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am
8-K
EX-3.2
qob0 cmxqc3
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am
8-K
EX-3.3
ap5is1l526gtq1thkv
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am
8-K
EX-3.1
oicho
27 Jan 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
u673bzvdu3ouhl9
6 Jan 11
Pro-pharmaceuticals Closes $2.1 Million Offering
12:00am
8-K
EX-3.1
8fs73c9 bp
17 Feb 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
jtigmjb
28 May 09
Departure of Directors or Certain Officers
12:00am